Overkill vs. Bioburden-Based Sterilization Validation: Which Release Method Fits Your Device?

Once you have selected a sterilization method, you still have to choose how product is released. The two dominant approaches — the overkill method and the bioburden-based (lethal-rate) method — trade simplicity against cycle aggressiveness and testing burden.

The overkill method

Overkill assumes a worst-case product bioburden and validates a cycle that delivers a large lethality margin — commonly a minimum 12-log reduction of a resistant biological indicator. Because the cycle already assumes the worst, release does not depend on lot-by-lot bioburden characterization. It is the simplest, most robust pathway and the fastest to validate.

The bioburden-based (lethal-rate) method

The lethal-rate method designs the cycle around your product’s actual measured bioburden, demonstrating lethality against the real population to achieve the required sterility assurance level (typically 10⁻⁶). The reward is a gentler, lower-cost cycle; the cost is routine bioburden monitoring and tighter process control.

How to choose

• Choose overkill when materials tolerate a more aggressive cycle and you want minimal routine testing
• Choose overkill when bioburden is variable, seasonal, or hard to characterize reliably
• Choose bioburden-based when materials are sensitive to aggressive exposure
• Choose bioburden-based when minimizing cost or exposure per lot matters and your environment is clean and well-controlled

Why in-house testing matters here

A bioburden-based method depends on reliable, repeatable bioburden and sterility data. When that testing happens in the same building as sterilization, characterization and monitoring stay fast and tightly coupled to the process — no shipping samples to an outside lab and waiting on turnaround.